Add time:08/21/2019         Source:sciencedirect.com

The results of several studies have shown favourable results with a once-a-month pill containing 2.5 mg Quingestanol (cas 10592-65-1) acetate and 2 mg quinestrol. In a multicentre study, 666 women were investigated for 3,130 woman months. Data analyzed using life-table method indicated a net cumulative continuation rate of only 15.0 per 100 users at the end of 12 months. Although the rate of discontinuing use of the pill for medical reasons was 42.2 per 100 users at 12 months, requests at the clinic for a “pill-a-month” method still continued. Further search for appropriate long-acting oral preparations is indicated for population groups included in this study.

We also recommend Trading Suppliers and Manufacturers of Quingestanol (cas 10592-65-1). Pls Click Website Link as below: cas 10592-65-1 suppliers